Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Airdoc Technology Co. Ltd. Class H ( (HK:2251) ) has issued an announcement.
Beijing Airdoc Technology Co., Ltd. has scheduled a board meeting for March 31, 2026 to review and approve the annual results for the year ended December 31, 2025, along with their release to the market. The board will also consider recommending a final dividend, signaling potential returns for shareholders depending on the company’s performance and capital allocation priorities.
The meeting date provides investors and other stakeholders with a clear timeline for when they can expect detailed financial disclosures and any decision on profit distribution. The announcement also confirms the current composition of the board, highlighting a mix of executive and independent non-executive directors that shapes the company’s corporate governance and oversight of its strategic direction.
The most recent analyst rating on (HK:2251) stock is a Hold with a HK$11.00 price target. To see the full list of analyst forecasts on Beijing Airdoc Technology Co. Ltd. Class H stock, see the HK:2251 Stock Forecast page.
More about Beijing Airdoc Technology Co. Ltd. Class H
Beijing Airdoc Technology Co., Ltd. is a Hong Kong–listed company in the technology and healthcare sector, focusing on artificial intelligence solutions for medical diagnostics and health management. It operates through subsidiaries to deliver AI-driven products and services aimed at improving clinical decision-making and preventive care across the Chinese market and beyond.
Average Trading Volume: 57,559
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.13B
Learn more about 2251 stock on TipRanks’ Stock Analysis page.